All Industries

Top Biotech Companies

5,081 Biotech companies, sorted by total funding raised.

TyraIPO

Clinical-stage biotech (Nasdaq: TYRA) developing precision medicines targeting acquired resistanc...

Carlsbad, United States51–200Biotech, Healthcare
Series A·$356.0M·Jan 2020
PIONYR ImmunotherapeuticsAcquired

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenviron...

South San Francisco, United States51–200Biotech, Healthcare
Corporate Round·$355.0M·Jun 2020
ExscientiaAcquired

AI-driven drug design and development company using machine learning to create more effective med...

Oxford, United Kingdom201–500Artificial Intelligence, Biotech
Series D·$351.0M·Apr 2021
Nephron Pharmaceuticals

Pharmaceutical manufacturing and specialty drug company.

West Columbia, United States501–1000Biotech, Healthcare
Venture Round·$350.0M·Aug 2023
PozenClosed

POZEN Inc. is a pharmaceutical company developing therapeutic advancements for diseases with unme...

Chapel Hill, United States11–50Biotech
Corporate Round·$350.0M
AffinivaxAcquired

Vaccine development platform leveraging technology from Boston Children's Hospital.

Cambridge, United States51–200Biotech, Healthcare
Series C·$348.5M·Jan 2021
Hemab Therapeutics

Bi-specific antibodies for hemophilia and rare bleeding disorders

Cambridge11–50Biotech, Healthcare
Series C·$347.0M·Mar 2026
Immatics N.V.IPO

Clinical-stage biopharmaceutical company developing T cell receptor-based adoptive cell therapies...

Tuebingen, Germany201–500Biotech, Healthcare
Corporate Round·$346.7M·Dec 2025
Remilk

Precision fermentation company producing animal-free dairy proteins.

Rehovot, Israel51–200Food Tech, Biotech
Venture Round·$346.3M·May 2026
Dewpoint Therapeutics

Biotech company applying biomolecular condensate science to drug discovery across oncology, neuro...

Boston, United States51–200Life Sciences, Biotech
Series D·$346.1M·Sep 2025
Anteris Technologies Global Corp.IPO

Anteris Technologies is a structural heart company developing the DurAVR biomimetic transcatheter...

Eagan, United States51–200Biotech, Healthcare
Growth Equity·$344.1M·Jan 2025
Avistone Pharmaceuticals

Clinical-stage precision oncology company developing innovative targeted therapies for cancer pat...

Beijing, China51–200Biotech, Healthcare
Series B·$340.0M·Jan 2024
Capstan TherapeuticsAcquired

Biotech developing in vivo CAR-T cell therapies. Acquired by AbbVie for $2.1B upfront in 2024.

San Diego, United States51–200Biotech, Healthcare
Series B·$340.0M·Mar 2024
Aspen Neuroscience

Biotech company developing the first autologous iPSC-derived neuron replacement cell therapy for ...

San Diego, United States51–200Biotech, Healthcare
Series C·$339.0M·Nov 2025
BlossomHill TherapeuticsAcquired

Small molecule drug discovery company developing treatments for unmet medical needs in oncology a...

San Diego, United States51–200Biotech, Healthcare
Venture Round·$339.0M·Dec 2025
Prime MedicineIPO

Biotechnology company developing one-time curative genetic therapies using Prime Editing, a preci...

Cambridge, United States201–500Biotech, Healthcare
Grant·$339.0M·Jul 2025
AgomAb Therapeutics NVIPO

Clinical-stage biopharmaceutical company developing novel disease-modifying therapies for immunol...

Antwerp, Belgium11–50Biotech, Healthcare
Series D·$337.8M·Jan 2024
Crystalys Therapeutics

Clinical-stage company transforming gout treatment with next-generation URAT1 inhibitor

San Diego, United States11–50Biotech, Healthcare
Series B·$335.0M·Jul 2026
GreenLight BioIPO

RNA biotech using a cell-free platform to produce RNA solutions for agriculture, human health, an...

Medford, United States51–200Biotech
Series C·$335.0M·Mar 2025
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Corporate Round·$335.0M·Dec 2024
ProFound Therapeutics

Biotech company pioneering discovery of an expanded human proteome to develop new medicines for c...

United States11–50Biotech
Series B·$333.0M·May 2026
Bolt Threads

Biotech company developing sustainable biomaterials including mycelium leather and silk proteins ...

Emeryville, United States11–50Biotech, Climate Tech
Series E·$332.3M·Nov 2024
Compass TherapeuticsIPO

Clinical-stage biotech developing novel antibody-based cancer therapies targeting the tumor micro...

Cambridge, United States11–50Biotech, Healthcare
Venture Round·$332.0M·Aug 2025
TruepillAcquired

API-connected healthcare infrastructure.

San Mateo, United States1001–5000Digital Health, Healthcare
Series D·$328.0M·Aug 2023
Varda

In-space pharmaceutical manufacturing company that designs, builds, and flies spacecraft to proce...

El Segundo, United States51–200Biotech, Manufacturing
Series C·$328.0M·Jul 2025